Product

Recombinant zoster vaccination

1 clinical trial

2 indications

Indication
Vaccination
Clinical trial
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
Status: Recruiting, Estimated PCD: 2026-03-31